NeuroSense Therapeutics Ltd. (NRSN)
NASDAQ: NRSN · Real-Time Price · USD
0.4531
+0.0100 (2.26%)
At close: Aug 14, 2026, 4:00 PM EDT
0.4920
+0.0389 (8.59%)
After-hours: Aug 14, 2026, 7:21 PM EDT
NeuroSense Therapeutics Market Cap
NeuroSense Therapeutics has a market cap or net worth of $16.75 million as of August 14, 2026. Its market cap has decreased by -45.53% in one year.
Market Cap
16.75M
Enterprise Value
16.76M
1-Year Change
-45.53%
Ranking
Category
Stock Price
$0.45
ChartMarket Cap Chart
Since the IPO on December 9, 2021, NeuroSense Therapeutics's market cap has decreased from $64.61M to $16.75M, a decrease of -74.07%. That is a compound annual growth rate of -25.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 16.75M | -26.65% |
| Dec 31, 2025 | 22.84M | -17.70% |
| Dec 31, 2024 | 27.75M | 158.68% |
| Dec 29, 2023 | 10.73M | -24.68% |
| Dec 30, 2022 | 14.24M | -46.24% |
| Dec 31, 2021 | 26.49M | -59.00% |
| Dec 9, 2021 | 64.61M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pluri | 19.10M |
| Werewolf Therapeutics | 18.94M |
| NewcelX | 17.85M |
| Cyclerion Therapeutics | 17.55M |
| Lipocine | 17.23M |
| Pasithea Therapeutics | 17.03M |
| Tvardi Therapeutics | 16.70M |
| KALA BIO | 16.61M |